¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"constant field gradient spin echo method"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • fast time constant circuit
    °í¼Ó½Ã°£°íÁ¤È¸·Î
  • filtration constant
    ¿©°ú»ó¼ö
  • growth rate constant
    Áõ½Ä·ü»ó¼ö
  • ionization constant
    ÀÌ¿ÂÈ­»ó¼ö
  • mean corpuscular constant
    Æò±ÕÀûÇ÷±¸»ó¼ö
  • polarization constant
    ºÐ±Ø»ó¼ö
  • permeability constant
    Åõ°ú»ó¼ö
  • phase constant
    À§»ó»ó¼ö
  • quantum constant
    ¾çÀÚ»ó¼ö
  • rate constant
    ¼Óµµ»ó¼ö
  • radioactive constant
    ¹æ»ç´É»ó¼ö
  • statistical constant
    Åë°è»ó¼ö
  • structural constant
    ±¸Á¶»ó¼ö
  • sedimentation constant
    ħ°­»ó¼ö
  • universal constant
    º¸Æí»ó¼ö
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • constant pain
    Áö¼ÓÅë
  • constant region
    ºÒº¯ºÎÀ§
  • constant strabismus
    ºÒº¯»ç½Ã, Áö¼Ó»ç½Ã
  • constant tachycardia
    Áö¼Óºü¸¥¸Æ
  • constant velocity
    °íÁ¤¼Óµµ
  • constant friction knee
    Á¤¸¶Âû¹«¸­°üÀý
  • corpuscular constant
    ÀûÇ÷±¸»ó¼ö
  • decay constant
    ºØ±«»ó¼ö
  • dielectric constant
    À¯ÀüÀ², À¯Àü»ó¼ö, ÅõÀü»ó¼ö
  • diffusion constant
    È®»ê»ó¼ö
  • dissociation constant
    ÇØ¸®Á¤¼ö
  • elastic constant
    ź·Â»ó¼ö
  • electrolytic dissociation constant
    Àü¸®»ó¼ö, ÀüÇØÁúÇØ¸®»ó¼ö
  • equilibrium constant
    ÆòÇü»ó¼ö
  • exposure rate constant
    ÇÇÆø·ü»ó¼ö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • alveolar O2 pressure gradient
    ÆóÆ÷³» »ê¼Ò ºÐ¾ÐÂ÷.
  • alveolar arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£ »ê¼ÒºÐ¾ÐÂ÷.
  • alveolar-arterial oxygen gradient
    ÆóÆ÷µ¿¸Æ°£ »ê¼ÒºÐ¾ÐÂ÷
  • frequency encoding gradient
    Á֯ļö ºÎȣȭ °æ»ç
  • gradient induced phase shift effect
    °æ»ç À¯µµ À§»ó º¯À§ È¿°ú
  • gradient limiting reabsorption
    ³óµµÁõ°¨Á¦ ÇѼº ÀçÈí¼ö.
  • gradient magnetic coil
    °æ»ç ÀÚ±â ÄÚÀÏ
  • gradient moment
    °æ»ç ¸ð¸àÆ®
  • gradient moment nulling (GMN)
    °æ»ç ¸ð¸àÆ® ¹«È¿È­
  • gradient motion rephasing (GMR)
    °æ»ç ¿îµ¿ ÀçÀ§»ó
  • gradient refocused acquisition
    °æ»ç ÀçÃÊÁ¡ ȹµæ
  • gradient refocused imaging
    °æ»ç ÀçÃÊÁ¡ ¿µ»ó
  • gradient shielding
    °æ»ç Â÷Æó
  • gradient slope
    °æ»ç ±â¿ï±â
  • gradient spoiling
    °æ»ç ȸ¼Õ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • constant tachycardia
    Áö¼Ó¼º (½É)ºó¹ÚÁõ(ò¥áÙàõãýÞºÚÑñø).
  • constant temperature bath
    Ç׿¿å
  • constant velocity
    °íÁ¤ ¼Óµµ
  • corpuscular constant
    ÀûÇ÷±¸»ó¼ö(ËøÌ´Ë´ Ë×?).
  • decay constant
    ºØ±«»ó¼ö
  • dielectric constant
    À¯ÀüÀ²(ë¯ï³ëÒ), À¯Àü»ó¼ö, ÅõÀü»ó¼ö.
  • diffusion constant
    È®»ê»ó¼ö(¡­ßÈâ¦).
  • dissociation constant
    ÇØ¸®Á¤¼ö(ú°ìÆïÒâ¦).
  • elastic constant
    ź¼º(÷¥àõ)»ó¼ö(ßÈâ¦).
  • electrolytic dissociation constant
    Àü¸®»ó¼ö(¡­ßÈâ¦), ÀüÇØÁúÇØ¸®»ó¼ö.
  • equilibrium constant
    ÆòÇü»ó¼ö(¡­ßÈâ¦).
  • exposure rate constant
    ÇÇÆøÀ²»ó¼ö
  • fast time constant circuit
    °í¼Ó ½Ã°£ °íÁ¤ ȸ·Î
  • fast time constant circuit
    °í¼Ó½Ã°£ °íÁ¤È¸·Î (ÍÔáÜãÁÊà ͳïÒüÞÖØ)
  • filtration constant
    ¿©°ú»ó¼ö(¡­ßÈâ¦).
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • dissymmetry constant
    "ºÒ¿ÏÀü ´ëĪ »ó¼ö(ÝÕèÇîïÓßöàßÈâ¦), (ÔÒ) frictional ratio"
  • equilibrium constant
    ÆòÇü»ó¼ö(øÁû¬ßÈâ¦)
  • exponential growth rate constant
    Áö¼ö ¼ºÀå¼Óµµ »ó¼ö (ò¦â¦à÷íþáÜÓøßÈâ¦)
  • formation constant
    Çü¼º »ó¼ö(û¡à÷ßÈâ¦)
  • gas constant
    ±âü »ó¼ö (Ѩô÷ßÈâ¦)
  • growth rate constant
    ¼ºÀå¼Óµµ »ó¼ö (à÷íþáÜÓøßÈâ¦)
  • hydrolysis constant
    °¡¼öºÐÇØ(Ê¥â©ÝÂú°) »ó¼ö(ßÈâ¦)
  • hydrophobicity constant
    ¼Ò¼ö¼º »ó¼ö(áÂâ©àõßÈâ¦)
  • rate constant
    ¼Óµµ»ó¼ö(áÜÓøßÈâ¦)
  • inhibition constant
    ÀúÇØ»ó¼ö(îÁúªßÈâ¦)
  • inhibitor constant
    ÀúÇØÁ¦»ó¼ö(îÁúªð¥ßÈâ¦)
  • intrinsic association constant
    °íÀ¯ ¿¬ÇÕ»ó¼ö(ͳêóÖ¤ùêßÈâ¦)
  • intrinsic dissociation constant
    °íÀ¯ ÇØ¸®»ó¼ö(ͳêóú°×îßÈâ¦)
  • ionization constant
    ÀÌ¿ÂÈ­(ûù) »ó¼ö(ßÈâ¦)
  • kinetic constant
    ¹ÝÀÀ¼Óµµ»ó¼ö(ÚãëëáÜÓøßÈâ¦)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • spin dephasing
    ½ºÇÉÅ»À§»ó
  • spin frequency
    ½ºÇÉÁ֯ļö
  • spin lattice relaxation
    ½ºÇɰÝÀÚÀÌ¿Ï
  • spin lattice relaxation time (T1)
    ½ºÇɰÝÀÚÀ̿Ͻð£(T1)
  • spin locking
    ½ºÇÉÀá±Ý
  • spin phase
    ½ºÇÉÀ§»ó
  • spin phase effect
    ½ºÇÉÀ§»óÈ¿°ú
  • spin quantum number
    ½ºÇɱ¤ÀÚ¼ö
  • spin warp
    ½ºÇɱÁÈû
  • spin warp imaging
    ½ºÇɱÁÈû¿µ»ó
  • T1 (spin lattice) relaxation
    T1(½ºÇɰÝÀÚ)ÀÌ¿Ï
  • demagnetizing field
    ¹ÝÀÚÀå
  • electromagnetic field
    ÀüÀÚ(±â)Àå
  • far field
    ¿ø°Å¸®±¸¿ª
  • field
    ¾ß, ¿µ¿ª, Çʵå, Ç׸ñ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
SDW spin density-weighted
spin spine, spinal
T1 spin-lattice or longitudinal relaxation time; tricuspid first sound
GRASS Gradient Recalled Acquisition at Steady State
AAG 3-alkaladenine deoxyribonucleic acid glycosylase; allergic angiitis and granulomatosis; alpha-1-acid...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 6
HPLC High-Performance Liquid Chromatographic method
LAM Lactational Amenorrhea Method
MEM Maximum Entropy Method
MDL method detection limit
D.C.C. dextran coated charcoal method
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • hepato renal echo contrast
    °£ ½ÅÀå ¿¡ÄÚ ´ëÁ¶
  • internal echo
    ³»ºÎ ¿¡ÄÚ
  • lateral wall echo
    Ãøº® ¸Þ¾Æ¸®
  • marginal echo
    °¡ÀåÀÚ¸® ¿¡ÄÚ, ÁÖº¯ ¿¡ÄÚ
  • midline echo shift
    Á¤Áß¼± ¿¡ÄÚ º¯À§
  • mixed echo
    È¥ÇÕ ¿¡ÄÚ, È¥ÇÕ ¸Þ¾Æ¸®
  • partial echo imaging
    ºÎºÐ ¿¡ÄÚ ¿µ»ó
  • posterior echo
    ÈÄ¹æ ¿¡ÄÚ
  • pulse echo principle
    ÆÞ½º ¿¡ÄÚ ¿ø¸®
  • rephasing even echo
    ÀçÀ§»ó ¦¼ö ¿¡ÄÚ
  • septum echo
    Áß°Ý ¿¡ÄÚ, °Ý¸· ¿¡ÄÚ
  • stimulated echo acquisition mode
    ÀÚ±Ø ¿¡ÄÚ È¹µæ ¹æ½Ä
  • ultrasound echo recording
    Doppler ÃÊÀ½ÆÄ ÃÔ¿µ¼ú, ÃÊÀ½ÆÄ ¹ÝÇâ ±â·Ï¹ý
    µÎ°³ ¿ÜÀÇ Æó»ö¼º Ç÷°ü ÁúȯÀÇ Áø´Ü¿¡ »ç¿ëÇÏ´Â °ÍÀ¸·Î °è¼ÓÀûÀÎ ÃÊÀ½ÆÄ ÆÄÀåÀÇ º¯È­·Î ½ÉºÎ Á¶Á÷ Ç÷°ü ³»ÀÇ Ç÷·ù ¼ÓµµÀÇ ºñÀ²À» °¡½Ã ±â·ÏÀ̳ª °èÃøÀ» ÇÒ ¼ö ÀÖ´Â ÃÊÀ½ÆÄ °Ë»ç¹ý. ¶ÇÇÑ ÀÌ ¹æ¹ýÀº žÆÀÇ ½ÉÀå ¹Úµ¿ÀÇ °Ë»ç³ª ¹Úµ¿Çϰí ÀÖ´Â ½ÉÀå ±¸Á¶ÀÇ ¿îµ¿ ¼Óµµ¸¦ °Ë»çÇÒ ¼ö ÀÖ´Ù.
  • absolute field
    Àý´ë ºÎ
    ´ë³úÀÇ ÀϺηÎ, ±× º´º¯¿¡ ÀÇÇØ °æ·Ã ¶Ç´Â ¸¶ºñ¸¦ ÀÏÀ¸Å²´Ù.
  • abutted field
    ÀÎÁ¢ Á¶»ç¸é
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
flotation constant Characteristic sedimentation behaviour of a lipoprotein fraction of plasma in a centrifugal field in a medium of appropriate density, achieved by adding a salt or D2O to the plasma.
Synonym: negative S, Svedberg of flotation.
(05 Mar 2000)
law of constant numbers in ovulation The number of ova discharged at each ovulation is nearly constant for any given species.
(05 Mar 2000)
auditory field The space included within the limits of hearing of a definite sound, as of a tuning fork.
(05 Mar 2000)
bright field illumination <microscopy> The method of lighting the specimen with a solid cone of rays. Transmitted bright field illumination is performed by a substage condenser. Reflected bright field illumination is performed by a vertical illuminator.
Compare: dark field illumination
(05 Aug 1998)
bright field imaging <microscopy> An imaging mode in a transmission electron microscopy that uses only unscattered Electrons to form the image. Contrast in such an image is due entirely to mass-thickness variations in amorphous samples, and may include diffraction contrast in crystalline samples.
(05 Aug 1998)
bright field microscopy <technique> Optical microscopy, in which absorption to a great extent and diffraction to a minor extent give rise to the image, as opposed to phase contrast or interference methods of microscopy.
(18 Nov 1997)
Broca's field The posterior part of the inferior frontal gyrus of the left or dominant hemisphere, corresponding approximately to Brodmann's area 44; Broca identified this region as an essential component of the motor mechanisms governing articulated speech.
Synonym: Broca's area, Broca's field, motor speech centre.
(05 Mar 2000)
cardioid dark field condenser <microscopy> A condenser designed with two reflecting surfaces, the first, a spherical surface which reflects the rays to a second, cardioid (heart-shaped) surface. The virtue in such an arrangement is that, if the cardioid surface is of true figure, the lens is both achromatic and aplanatic. It has a limiting numerical aperture of about 1.0. Thus objectives of a greater numerical aperture cannot be used successfully with it. A true cardioid figure is the trace of a point on the circumference of a circle rolling around an equal, fixed circle.
(05 Aug 1998)
magnetic field The sphere of influence of a magnet.
(05 Mar 2000)
paraboloid dark field condenser <microscopy> A lens of parabolic shape. The vertex end is ground back so that its focus can be brought into coincidence with the specimen on the slide. A central stop is provided to block the central rays. It is used chiefly for medium- power work.
(05 Aug 1998)
receptive field That part of the retina whose photoreceptors (rods and cones) pertain to a single optic nerve fibre. The response of a neuron to stimulation of its receptive field depends on the type of neuron and the part of the field that is illuminated; an "on-centre" neuron is stimulated by light falling at the centre of its receptive field and inhibited by light falling at the periphery; an "off-centre" neuron reacts in exactly the opposite fashion; that is, it is inhibited by light falling at the centre of its receptive field. In either case, the net response depends on a complex switching action in the retina. When an entire receptive field is equally illuminated, the response of receptors at the centre of the field predominates.
(05 Mar 2000)
visual field The area simultaneously visible to one eye without movement; often measured by means of a bowl perimeter located 330 mm from the eye.
(05 Mar 2000)
visual field test <ophthalmology> A test which measures the extent of visual field loss. This test may be performed by a number of methods including confrontation, tangent screen exam and automated perimetry.
Diseases that affect visual field include stroke, diabetes, hypertension, multiple sclerosis, glaucoma, hyperthyroidism, Jacob-Creutzfeldt disease and optic glioma.
(27 Sep 1997)
reversed-field pinch <radiobiology> A toroidal magnetic confinement scheme which could constitute an alternative to the Tokamak for building a fusion reactor. It is characterised by a magnetic field mostly generated by the plasma itself, with toroidal and poloidal components of comparable intensities, in contrast with the Tokamak where most of the field is toroidal and externally applied. The name of the configuration is given by the fact that the toroidal component of the magnetic field changes sign in the outer region of the plasma. The main attractivness of the Reversed Field Pinch is that, according to presently established scalings, it could reach ignition without the need of auxiliary heating.
(09 Oct 1997)
rice-field fever A febrile illness affecting workers in rice fields, reported in Po valley in Italy and in Sumatra, caused by infection with a species of Leptospira.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
  • field hockey
    À°»ó ÇÏŰ
  • field hospital
    ¾ßÀü º´¿ø
  • field house
    °æ±âÀåÀÇ ºÎ¼Ó °Ç¹°;½Ç³»°æ±âÀå
  • field ice
    ºù¿ø;¾ßºù
  • field intensity
    ÀåÀÇ ¼¼±â;Àü°èÀÇ °­µµ
  • field ion microscope
    À̿ ¹æ»ç Çö¹Ì°æ;Àü°è À̿ Çö¹Ì°æ
  • field jacket
    ¾ßÀü¿ë ÀçŶ
  • field judge
    ÇÊµå ½ÉÆÇ
  • field kitchen
    ¾ß¿Ü(¾ßÀü)Ãë»çÀå
  • field lacrosse
    ¶óÅ©·Î½º
  • field lark
    =MEADOWLARK
  • field length
    ÀÌÂø·ú ȰÁÖ °Å¸®
  • field lens
    ´ë¹° ·»Áî;½Ã¿ª ·»Áî
  • field line
    ÈûÀÇ ¼±
  • field magnet
    °èÀÚ;ÀåÀÚ¼®
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 6
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 6
ÅëÇÕ°Ë»ö ¿Ï·á